-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qq4bQDD0vJbQ58Eg7eNLJ1VBOJigHL1OwAGuFMElGarRgR7+LtX1AIQzk1k8BIO4 oaYOyPmfvUEOZVFrE656CQ== 0001193125-04-138601.txt : 20040812 0001193125-04-138601.hdr.sgml : 20040812 20040812084642 ACCESSION NUMBER: 0001193125-04-138601 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20040811 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20040812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORASURE TECHNOLOGIES INC CENTRAL INDEX KEY: 0001116463 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364370966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16537 FILM NUMBER: 04968534 BUSINESS ADDRESS: STREET 1: 150 WEBSTER ST CITY: BETHLEHEM STATE: PA ZIP: 18015 BUSINESS PHONE: 5036416115 MAIL ADDRESS: STREET 1: 150 WEBSTER ST CITY: BETHLEHEM STATE: PA ZIP: 18015 8-K 1 d8k.htm ORASURE TECHNOLOGIES--FORM 8-K Orasure Technologies--Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 11, 2004

 


 

OraSure Technologies, Inc.

(Exact name of issuer as specified in charter)

 


 

DELAWARE   001-16537   36-4370966

(State or Other Jurisdiction of

Incorporation or Organization)

  (Commission file number)  

(I.R.S. Employer

Identification Number)

 

220 East First Street

Bethlehem, Pennsylvania 18015-1360

(Address of principal executive offices)

 

(610) 882-1820

(Registrant’s telephone number, including area code)

 



Item 5 – Other Events and Regulation FD Disclosure.

 

OraSure Technologies, Inc. (the “Company”) issued a press release announcing that its 2005 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 17, 2005, at the Radisson Hotel Bethlehem, Bethlehem, Pennsylvania, 18018. The information contained in the press release dated August 11, 2004 is incorporated herein by reference and attached to this Current Report on Form 8-K as Exhibit 99.

 

Item 7. Financial Statements and Exhibits

 

(c) Exhibits

 

Exhibit

Number


 

Description


99   Press Release dated August 11, 2004, announcing that the OraSure Technologies, Inc. 2005 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 17, 2005, at the Radisson Hotel Bethlehem, Bethlehem, Pennsylvania, 18018.

 

2


Signatures

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

    ORASURE TECHNOLOGIES, INC.
Date: August 12, 2004   By:  

/s/ Jack E. Jerrett


        Jack E. Jerrett
       

Senior Vice President, General Counsel

and Secretary

 

3


Index to Exhibits

 

Exhibit

Number


 

Description


99   Press Release dated August 11, 2004, announcing that the OraSure Technologies, Inc. 2005 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 17, 2005, at the Radisson Hotel Bethlehem, Bethlehem, Pennsylvania, 18018.

 

4

EX-99 2 dex99.htm PRESS RELEASE Press Release

Exhibit 99

 

LOGO

 

Company Contact:

 

Ronald H. Spair

Chief Financial Officer

610-882-1820

Investorinfo@orasure.com

www.orasure.com

 

ORASURE TECHNOLOGIES SETS 2005 ANNUAL MEETING DATE

 

Bethlehem, PA – (August 11, 2004) – OraSure Technologies, Inc. (Nasdaq NM:OSUR) today announced that its 2005 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 17, 2005, at the Radisson Hotel Bethlehem, Bethlehem, Pennsylvania, 18018. Stockholder proposals must be received no later than December 11, 2004, in order to be considered for inclusion in the Company’s Proxy Statement under relevant Securities and Exchange Commission rules and no later than February 16, 2005, in order to be considered at the Annual Meeting or to nominate a Director under OraSure Technologies’ Bylaws.

 

About OraSure Technologies

 

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.

 

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.

 

# # #

GRAPHIC 3 g379341.jpg GRAPHIC begin 644 g379341.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#BFB?H]QUHYT'LVA%:NH:&+_PQ8:DB9EM0;:?W4'Y3^&GRRZ?/=@'$#HK#_`'L_X57\I_[IKT?1M%$OA77%V\_NV7_@))JAX?\` M#8U'68(9%_'ETZVBAE7-W*`\B_P#/)>R_4]3^%5[1 M:7%[-G$^4_\`=-'E/_=-=/\`V4?[IH_LK_9I\Z#D9R_E/_=-?0_A<8\+:6#_ M`,^D?_H(KQ_^RO\`9KV704\O0+!/[MN@_05R8J5TC:E&S9H4445PFX4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`'GQTL9/%*ND%SA5R?3O74_81Z4?8/:NGVA-CFH+-K:0_(&4\/&XX M8>A%67\/0W49GL,\?>@8_,OT/<5T2PAAMGC$@[$]1^-.2P6-Q);N5([&I=1A M8Q;&QCO[$Z9=C#Q9,#D2/R8E$<7?MFJ51WN%CE)M/M[=3#;#>W1Y MB.OLOH/>JG]EC^[78?V?"GWLN?0<"F/:;N`H5?115JH*QR7]ECTKN=.3R]-M MD_NQ*/TJA]A'I6K"NR%%]%`J)RYAI6'T445D,****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@!NT>E+@4M M%`";1Z"C:!TI:*`"BBH[@.UO((_OE3CZU,G9-C6K$6XB:0HK;B.N!G%2UB6= MXMNNT_*1U!J_9SOV:\_T_7?% M&CZCX;N[W6VU"WUTC?;R(`(P2!P?^!#IZ5V'Q._Y$#4OHG_H:UP^I?ZGX=?1 M/_0DKKHQ3AJN_P"1C-NYZC)XDT2*>6"35+5989%BD0R#&-&T[5?B9XGEOK5+AK:X#P[QD(VX\X]>*YOQ MK#H=G;:I:Z5#<7]U]M$MYJ,H4K`Y)_=JV,G)S^5*-&+ERCF:BOBZ1XH[&?9'>W*>6)5 M)(SGOR.OO3/%OAH>(M`L)[*<1:U9PK+:L'`9^`2OZ9!]:Q=4\4MXG^$FIO3_S$VTVST-=*\YL?^1^\%_P#8'3_T%ZL_ M#S1]/OO$7B*^NK5)KBTOR8';GRSN8Y'OP*ATHI-M_P!7&IMNQW;>)]"34_[- M;5K07F[;Y)E&[=Z?7VK1G222WD2*3RY&0A7QG:<<&OG^QT^\UCPU0N/NYQC%>A/XBTG1A;Z?JVMVJWHC4/YCA2[8^\1VSUKD7_Y+ MU'_UY?\`LAKE+^WGU+Q#XPM8-#FU2ZFFV131J";;#'GGID#''I6S@IVOIHF1 M=Q/9=2UO2](MTN-1OX+:*0X1I'`W?3UKF_'OB*2W\"OJV@ZBN3*@2>$AA@G! M'>N3&GM)XM\%:9J]L7V:=MEMYQD`C?P1^`_*IO%?A7_A$_AMJ5JEZ;F.>^25 M1LVB/)`P.3Z5$:<5*-WK_P`$;DVF>@:+K^G:@D%DFHP3WZVZ/-$K@L#M&20/ MK2-XO\.(H9M:L@#)Y7^N'WO2N#T2SM;#XJZ1':6\<"/I"NRQK@%BAR3[UR4M ME:MX%UR]:WC-RFKJBS%?F53G@'TIJA%O?M^(>T:1[EJ>O:3HJQMJ6HV]J)/N M>8X!;Z"N7^(OB*YL?"]EJ.AZB$$]TJB:$JP=2#WY]*Y^\M;?4OB;96]]"EQ" MNB@A)!N`/EL@VTZ=))IBE-ZH]HU'Q#H^C>4NIZE; MVKRC*K*X!/OBK$VJ6%OIW]HRWD"6>T-YY<;"#T.:\SU:SMM1^)FMQWL"7"0Z M,6C609"$1K@CWY/YUCNQ?X2:$LS9A&K;7#'Y=N6X/MUJ5032U[?B5[1ZGJ\? MB31M1ML6&L6KO,KB)DD!.57)./8+YK*WMC##%B!XE!5,J<[2.F?:N3E8CX0Z0N=[GMNF:YI6LPO+INH0721\.8W!V_7TJ*R\3:'J5ZUE9:K:W%RN?W< M<@)..N/7\*\_T+0=2N_$NNRPZ%<:'9:AIK0Q(ZA55\*.WOD_G4?@&PT0:I:Z M5JVGM8>(M(9C&0VW[0,DYX^]@'\NE2Z44F[CYWH>L5PWQ-UO4]%M]);3;M[8 MSW>R0J`=RXZ-=ZY96M]\5]0CN[>.=% MTEG59%R`P3@_6N98E_A=HD+$F-]78,O8CFM8T$TM>Q#J-7/:],UK3-:A:73+ MZ"[1#AC$X.T^_I5ZN8T3P9!H7BF_U>SG6."\C""SCB"K'C'/7V/;O73USR44 M_=-5>VI'YJ^M'FKZUB?V@/6E74$')^;V[57(%S;#ANG-*74=2,UBG4VD#J>`>?2JMS=&&);F(AXCU_QJ/[1%?(6MW`E`Y0]356$72X7KQ2>:OK6/ M_:;QDHQZ<%6I&U%#R/E/IU%5R,5S9\U?6G@Y&:P?[0'K6W`V^WC;U4&E*-AF M7XKT5_$/AJ\TN.4123H-CMT#`@C/MQ7"Z;X,\5WVHZ#%K$5G:V6AD;'BDW-* M`0>GX#TKU*BJC5E%61+BF[G(^&?#NHZ7XP\0:G=+&+;4)`T!5\DC)ZCMUKCK MGX?>+AIFIZ1!'8O:7%Z+E96EP\G7'TX.3FO7Z*I5I)W]/P$X)JQY]KOA7Q!# MX@TKQ)H4=M/=VMLL$MO.^!D*1D'OP3^54;/P!KK^&/$0O6MTU+6'6184?Y%* MONP3TYR:]/HH5:25@Y$>;:+X2\3IXGT'4]3BLDATZU^SLL,A+*H#`9SU)SVX MK:\$^'-1T.^UV6_2-4OKOS8=C[LKENOIU%=?12E5E)6!02/)?^%?^+(;:;P_ M;26J:9+??:?MHE*R`8QC:/;MZ]Z]7B011)&"2$4#)ZG%/HI3J.>XXQ4=CC6\ M,ZD?BHGB()']@%MY9;?\V=I'3ZUAZSX+\40ZOKG]C"UEM-<(+RR2E'A^;)Q^ M.?7BO3J*:JR3$X)GGFI^#-=L+GP_J>C/!?7>DVWD2)<.5$G7YL_\"/Z52/P^ MUP?#^]TQGAEU*^NUN&3S/D0`]-QKU"BFJTD'(CB+3PMJD/C[3M9=(OLEOIRV M\A$GS;PI'`],U@-\/M?/@_5=,\JW^TW6I"XC'G<%!ZGL:]6HH5:2#D1Y[KGA M7Q#!X@LM>T..UN)DL1:RPSOM"G:5R#WZ_I5"X^'>LI\/[/183!+>B^^U3#?A M5!!&`>_:O4:*%6DK>0OZ/=^&?AWI6@&>UGNI[L>9;,"?M!+9V*>W)&3Q]:]6K'\0^%]+\3VT<.I1. MWDMNBDC M/)['OVJLOP[UF3X)(-,33DC8VUSYDG MF/M^7':NKM[6WM%=;>".$.Y=@B@;F/4GW-35//:?-%#Y;JS.*O/"^J3>/[S6 M42+[)-IS6Z$O\V\KCIZ5B#X>ZVWP^M-,S`FI65ZURB%\HX],UZA15*M)6$X) MG`Z'X>\4PZEKGB*]%K!J=Y;&.UMHY-T:O@8)]LJ/UJ'_`(NS_P!0G]*]$HI> MU=]4@Y/,\R_M3_:_6C^U/]K]:XS^U3_>H_M4_P!ZN_V1C[1'=PZZ+9=T0!F/ M_+1OX/H/7WI+>]FO[Q(468]/4GV%<+_`&J?[U2QZZ\,,B1MM,HVLV>= MOI^/>DZ78?M$>@:GXAAV+8V3_P"C1<%_^>A]?I5N[U06'AJTA#8ENP7/LN?_ M`-5>8)J1=U0-RQ`%7M;\0K>ZDQB?]Q"HAA_W5&`?QZ_C4>QU2'[1'I5MJ8/@ MN:?=RF8_S/\`]>J^@:JM_:76F,WSF-FB]_4?GS7$VVO!?!5]`7^;[9'@>Q!/ M_LM9=AXAET^^ANXF^>%PP'KZC\14JA=,/:+0[W2_$:6[-;7?S6LO#CNGO4%] M=2:=>M%YF<8:.13]Y3T(-<;JFIQ+JT1V?]J?[7ZUZ'IK;],MG_O1*?TKPDZJKW#06WZ!I[_P!ZVC/_ M`(Z*Y\1#E2+A*Y?)`!).`.I-48=:L;AF6"1I=EP+=BBD@.5W=?3!ZT[6;.34 M-%O;*%@LEQ`\:D]`2"!FN=T[PU?P10[X+:WVZHEV8HGRJH(MA`X'.:YXI-:L MMMW.K$\+,ZB5"8_O@,/E^OI3?MEKY?F?:8MG][>,>O6N$N?#>J6L&OWEQ!&W MVJTD14M.2[&0LIVA<]#SG)ZTFFZ!+JVB11K8+"T=W<23":,(DC/"R@HN/NAF M`YZ8-7[.-KW%S/L=\9X1(D9E0.XRJEAEA[#O40SZW&\-I':WT4 MBQ@GS&+LS'.=H(7G."3@].*GECW'=]CI8-2M;DP>1)YBW$1EC=1\I7COVZU8 MBFBG3?#(DBYQN1@1^EPM+)F9?DMF+!L(J[CP!DX[#ICO2<4EHP39K+/"QD"S(3%]\!A\OU M]*@?4[1)K6+S@QO&982GS!B`2>1[`UR8\):D%UV"..UAAOXF$67W,SERWWMH M(4@\@YP3QQ5S3/#M];RV,TD5O`L5]<7+01MD1+(A"J.!GD^U/ECW%=]CHKG4 M;.TM);N>YC2&%-[ONR`OK1'?6\LJQH^X-%YP<#Y2N<=>EM7+WP[?7L$H2."U,FD&S$8?(23=G'`^[[T^6.U MPN^QTOVNV\D3?:(O+;H^\;3^-.,\(D6,RH'<95=PRP]AWKC?^$1O)].CAEM; M2(&\N+@VX;%D4#C!^8@]*G/AK4$UG1[R**V)M8(8KB1WW<(#G"D=>>&! M'?-+ECW"[['1:CJUII9MQ=.0US*(8E49+,?;^M6?M$)=T\Z/=&,NNX94>_I6 M;K.DG4KS2IA'$XL[KS7\PS^'-.TV2VM%>S@N M(F&[*LS1E5<<=<\^U$5%[L&V=F9XA*(3*@D89";ADCUQ1)/##CS943/3+?#EQKKQM"D#>7: MSQKYIZ.Q3:1Q_LGFCEC=*X7=MCHO/B$ODF5/,QNV;AG'KCTH$\+8Q*ASC&&' M.>E5L*[<<\\]<8[9JCH'@B_TSQ#%>W%S'):Q M,Y6,$\!04AQ]$9LT)('"6LD0\WL[/&01QZ*W--LO#=U:W5BRK"D5M?74Y5# M@!)`P4`8]QQ1RQM>X7=]C9L]ME37WAO4WAD,"P.YU&> MX"O(5&R2-D'.#R-W2CECW"[['4O=6T>-]Q$N1D;G`R/6I00RAE(((R".]<5= M^#;JZ-J9(K63R;:SB._G!C9B^..A!'UKHM(T^XL=%L;.8KYEO;QQOM.1E5`. M/RJ7%):,:;['SK1117M'`%%%%`!FBBB@!PD<1F,,=C$$CU(Z?S--HHH`,GUH MHHH`****``]*^B_#7_(LZ9_UZ1_^@BBBN+&?"C>ANS3HHHKSSJ"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` &HHHH`__9 ` end
-----END PRIVACY-ENHANCED MESSAGE-----